EMERGING MARKETS CORPORATE BONDS UPDATE
- Pfizer/BioNTech Vakzine study indicates vaccine with 90% prevention rate.
- China plans to move from emerging market to a dominant global player with “quality over quantity” principle.
- EM companies report good figures.
Our fund’s performance in October was slightly better
than the benchmark. So far, very satisfying performance in November. To
continue a spread tightening, we have expanded our positions in convertible